ArticleFrontiers in pharmacology2022

Setanaxib (GKT137831) Ameliorates Doxorubicin-Induced Cardiotoxicity by Inhibiting the NOX1/NOX4/Reactive Oxygen Species/MAPK Pathway.

Hui Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.